Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 13th International Myeloma Workshop
Increasing Response and Reducing Adverse Events: An Exploration of Dosing Schedules and Combination Therapies for Multiple Myeloma
Paris, France / May 3-6, 2011
Paris - Proteasome inhibitor-containing regimens have improved response rates and response duration across all disease stages of multiple myeloma (MM) in transplant-eligible and -ineligible patients. New data presented here at the Myeloma...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
A First-line Option for Second-generation TKIs in Chronic Myeloid Leukemia
Orlando, Florida / December 4-7, 2010
Orlando - Second-generation tyrosine kinase inhibitors (TKIs) are replacing imatinib as first-line therapy for Philadelphia chromosome-positive chronic myeloid leukemia (CML), according to practice-changing data presented at the ASH...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Evaluating Anticancer Effects of Bisphosphonates in Myeloma
Orlando, Florida / December 4-7, 2010
Orlando - Bisphosphonates have demonstrated efficacy for preventing skeletal-related events in multiple myeloma and other cancers. Beyond the beneficial bone effects, evidence had emerged to suggest that nitrogen-containing bisphosphonates...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Expanding Iron Chelation Applications: New Data on Organ Protection
Orlando, Florida / December 4-7, 2010
Orlando - The role of iron chelators, long employed in thalassemia, was supported in an expanding list of both malignant and non-malignant hematological diseases in a series of studies presented at ASH. The ability of iron chelators to...
MEDICAL FRONTIERS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Greater Prophylaxis from Venous Thromboembolism for Cancer Patients
Orlando, Florida / December 4-7, 2010
Orlando - The more than twofold increase in rates of venous thromboembolism (VTE) in cancer patients over a recent 5-year period has identified a growing crisis in comprehensive care of patients with malignancy. The causes of the rising...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Validating the Subcutaneous Route in Multiple Myeloma Maintenance Therapy
Orlando, Florida / December 4-7, 2010
Orlando - New phase III data demonstrating that subcutaneous (s.c.) administration of a drug commonly administered intravenously (i.v.) is as effective but better tolerated in the treatment of multiple myeloma (MM) has been proposed as a...
PRIORITY PRESS - 52nd Annual Meeting and Exposition of the American Society of Hematology
Defining Disease Burden and Treatment Efficacy in Paroxysmal Nocturnal Hemoglobinuria
Orlando, Florida / December 4-7, 2010
Orlando - Paroxysmal nocturnal hemoglobinuria (PNH) confers a high risk of morbidity and mortality. In half of patients, the severe and persistent hemolysis that characterizes the disease leads to thromboses involving the liver and cerebral...
FRONTLINE - Hematology/Oncology
Evolving Standards of Therapy in Multiple Myeloma
June 2010
Reviewed and edited by: Kevin W
PRIORITY PRESS - 15th Congress of the European Hematology Association
Update on the Treatment of Iron Overload
Barcelona, Spain / June 10-13, 2010
Barcelona - Patients who become transfusion-dependent due to chronic anemia are highly predisposed to iron overload and iron overload in turn is toxic to many organs. Guidelines indicate that patients with high serum ferritin concentrations...